BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Provectus Biopharmaceuticals Inc. 

7327 Oak Ridge Highway Suite B

Knoxville  Tennessee  37931  U.S.A.
Phone: 866-594-5999 Fax:


SEARCH JOBS








 Company News
Provectus Biopharmaceuticals Inc. Signs Agreement With China’s Tririver Capital 4/14/2014 9:35:44 AM    More...
Provectus Biopharmaceuticals Inc. Release: Induction Of Systemic Immunity Following Treatment Of Tumors With PV-10 Reported By Moffitt Cancer Center Researchers At American Association for Cancer Research Annual Meeting 4/7/2014 9:42:15 AM    More...
Provectus Biopharmaceuticals Inc.’ PV-10 Data To Feature In Poster Presentation By Moffitt Cancer Center At The American Society of Clinical Oncology Annual Meeting 4/2/2014 7:11:42 AM    More...
Provectus Biopharmaceuticals Inc.’s PV-10 Data To Be Presented At The American Society of Clinical Oncology Annual Meeting 4/1/2014 7:09:32 AM    More...
Provectus Pharmaceuticals Inc. Submits Application To FDA To Receive Breakthrough Therapy Designation For PV-10 For Treatment Of Melanoma 3/24/2014 8:10:21 AM    More...
Provectus Pharmaceuticals Inc. Appoints Dr. Joseph M. Chalil To Strategic Advisory Board 3/19/2014 7:23:13 AM    More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 3/13/2014 11:17:51 AM    More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 2/28/2014 10:38:37 AM    More...
Provectus Pharmaceuticals Inc. Melanoma Version Of PV-10 Completes Phase 2 And Is Prepping For BTD 2/27/2014 9:57:50 AM    More...
Provectus Pharmaceuticals Inc.'s PV-10 Path To Initial Approval In U.S. Now Clear Per FDA Meeting Minutes 1/24/2014 9:32:18 AM    More...
12345678910...

//-->